Sibayan, Normina B.

HRN: 22-40-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/29/2022
01/04/2023
IV
1.5g
Q6
CAP MR; Presumptive PTB; Mild Pleural Effusion, Right Prob Sec To #2
Waiting Final Action 
01/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/01/2023
01/07/2023
IV
4.5g
Q6h
CAP HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: